content/02.introduction.md:145:infodemics
content/20.treatments.md:303:macrolide
content/20.treatments.md:308:macrolide
content/20.treatments.md:308:macrolide
content/20.treatments.md:309:macrolide
content/20.treatments.md:309:macrolide
content/20.treatments.md:310:macrolide
content/20.treatments.md:311:macrolide
content/20.treatments.md:312:macrolide
content/20.treatments.md:351:DSHEA
content/20.treatments.md:354:labelling
content/20.treatments.md:355:EFSA
content/20.treatments.md:356:EFSA
content/20.treatments.md:378:phagocytosis
content/20.treatments.md:380:hypothesised
content/20.treatments.md:385:antithrombotic
content/20.treatments.md:385:prothrombotic
content/20.treatments.md:386:antiplatelet
content/20.treatments.md:387:antiplatelet
content/20.treatments.md:387:investigational
content/20.treatments.md:388:antiplatelet
content/20.treatments.md:475:dimorphism
content/20.treatments.md:477:Biobank
content/20.treatments.md:478:Biobank
